tiprankstipranks
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market
APLLTD
Alembic Pharmaceuticals Limited
RESEARCH TOOLSreports
Want to see IN:APLLTD full AI Analyst Report?

Alembic Pharmaceuticals Limited (APLLTD) Financial Statements

2 Followers

Alembic Pharmaceuticals Limited Financial Overview

Alembic Pharmaceuticals Limited's market cap is currently ₹147.95B. The company's EPS TTM is ₹32.24; its P/E ratio is 19.32; and it has a dividend yield of 1.28%. Alembic Pharmaceuticals Limited is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ₹5.40. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 73.45B₹ 66.72B₹ 62.29B₹ 56.53B₹ 53.06B
Gross Profit₹ 33.10B₹ 47.91B₹ 44.33B₹ 38.78B₹ 38.08B
Operating Income₹ 8.00B₹ 27.02B₹ 25.08B₹ 19.81B₹ 18.31B
EBITDA₹ 11.18B₹ 9.89B₹ 9.14B₹ 6.96B₹ 8.59B
Net Income₹ 6.75B₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B
Balance Sheet
Cash & Short-Term Investments₹ 2.03B₹ 901.00M₹ 1.20B₹ 754.80M₹ 610.90M
Total Assets₹ 87.63B₹ 77.73B₹ 64.46B₹ 61.83B₹ 71.22B
Total Debt₹ 14.30B₹ 12.57B₹ 5.13B₹ 7.22B₹ 7.17B
Net Debt₹ 12.27B₹ 11.67B₹ 3.93B₹ 6.47B₹ 6.56B
Total Liabilities₹ 30.94B₹ 25.83B₹ 16.27B₹ 18.12B₹ 18.84B
Stockholders' Equity₹ 56.75B₹ 51.91B₹ 48.18B₹ 43.70B₹ 52.38B
Cash Flow
Free Cash Flow₹ 2.61B₹ -4.76B₹ 4.76B₹ 2.81B₹ 1.27B
Operating Cash Flow₹ 6.95B₹ 879.70M₹ 8.03B₹ 7.24B₹ 5.52B
Investing Cash Flow₹ -5.07B₹ -5.68B₹ -3.21B₹ -4.48B₹ -3.72B
Financing Cash Flow₹ -756.50M₹ 4.44B₹ -4.38B₹ -2.62B₹ -2.17B
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Alembic Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Alembic Pharmaceuticals Limited Cash Flow

Cash Flow >

Alembic Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >